BSN HESI 315 Pharmacology Exam V2 Complete Practice Test Bank — 300 Exam-Style Questions
with Verified Answers & Detailed Rationales | All Core Domains Covered | A+ Graded
Table of Contents
Exam Overview ...... 3
Domain 1: Pharmacokinetics & Pharmacodynamics (Questions 1–40) ...... 4
Domain 2: Autonomic Nervous System Pharmacology (Questions 41–70) ...... 8
Domain 3: Central Nervous System Drugs (Questions 71–105) ...... 11
Domain 4: Cardiovascular Drugs (Questions 106–150) ...... 15
Domain 5: Respiratory & Endocrine Drugs (Questions 151–190) ...... 20
Domain 6: Antibiotics & Anti-Infectives (Questions 191–225) ...... 24
Domain 7: GI, Renal, & Reproductive Drugs (Questions 226–255) ...... 27
Domain 8: Oncology, Immunosuppressants, & Special Populations (Questions 256–280) ...... 30
Domain 9: Nursing Considerations & Patient Safety (Questions 281–300) ...... 32
Answer Key ...... 35
,---
Exam Overview
The BSN HESI 315 Pharmacology Exam V2 is a comprehensive pharmacology assessment
designed for Bachelor of Science in Nursing (BSN) students. This examination evaluates mastery
of pharmacological principles, medication administration, drug classifications, adverse effects,
nursing interventions, and patient education across all body systems.
| Exam Detail | Information |
|-------------|-------------|
| Course | HESI 315: Pharmacology |
| Format | Multiple-choice, select-all-that-apply, clinical scenarios |
| Key Topics | Pharmacokinetics, drug classifications, adverse effects, nursing interventions,
patient education, dosage calculations |
| Passing Score | Typically 850–900 (scaled) |
Core Competencies Assessed:
- Pharmacokinetics & Pharmacodynamics — Absorption, distribution, metabolism, excretion,
receptor theory
- Autonomic Nervous System Drugs — Cholinergics, anticholinergics, adrenergics, adrenergic
blockers
- Central Nervous System Drugs — Antidepressants, antipsychotics, anxiolytics, anticonvulsants,
Parkinson's drugs
- Cardiovascular Drugs — Antihypertensives, antiarrhythmics, anticoagulants, cardiac glycosides
- Respiratory & Endocrine Drugs — Bronchodilators, steroids, insulin, thyroid medications
,- Antibiotics & Anti-Infectives — Penicillins, cephalosporins, aminoglycosides, antifungals,
antivirals
- GI, Renal, & Reproductive Drugs — Antacids, diuretics, hormonal contraceptives
- Oncology & Immunosuppressants — Chemotherapeutic agents, immunosuppressants
- Nursing Considerations — Medication administration, adverse effects, patient education,
safety
---
Domain 1: Pharmacokinetics & Pharmacodynamics (Questions 1–40)
---
Q1. A nurse is reviewing the pharmacokinetics of a medication. Which phase describes the
movement of a drug from the site of administration into the bloodstream?
A) Distribution
B) Metabolism
C) Absorption
D) Excretion
Answer: C
Rationale: Absorption is the process by which a medication moves from the site of
administration into the bloodstream. Distribution refers to the transport of the drug to tissues
and organs. Metabolism is the biotransformation of the drug. Excretion is the elimination of the
drug from the body.
, ---
Q2. A client is prescribed a medication that is highly protein-bound. Which of the following is a
potential risk associated with this type of medication?
A) Increased drug excretion
B) Decreased drug absorption
C) Drug interactions due to displacement from protein binding sites
D) Increased drug metabolism
Answer: C
Rationale: Highly protein-bound medications can interact with other highly protein-bound
drugs. When two protein-bound drugs are administered, they compete for binding sites,
potentially displacing one drug and increasing the concentration of free (active) drug, which can
lead to toxicity.
---
Q3. A nurse is educating a client about a medication that is metabolized by the liver. The client
has a history of liver disease. Which of the following effects should the nurse anticipate?
A) Decreased drug effect
B) Prolonged drug effect and increased risk of toxicity
C) No change in drug effect
D) Increased drug excretion
with Verified Answers & Detailed Rationales | All Core Domains Covered | A+ Graded
Table of Contents
Exam Overview ...... 3
Domain 1: Pharmacokinetics & Pharmacodynamics (Questions 1–40) ...... 4
Domain 2: Autonomic Nervous System Pharmacology (Questions 41–70) ...... 8
Domain 3: Central Nervous System Drugs (Questions 71–105) ...... 11
Domain 4: Cardiovascular Drugs (Questions 106–150) ...... 15
Domain 5: Respiratory & Endocrine Drugs (Questions 151–190) ...... 20
Domain 6: Antibiotics & Anti-Infectives (Questions 191–225) ...... 24
Domain 7: GI, Renal, & Reproductive Drugs (Questions 226–255) ...... 27
Domain 8: Oncology, Immunosuppressants, & Special Populations (Questions 256–280) ...... 30
Domain 9: Nursing Considerations & Patient Safety (Questions 281–300) ...... 32
Answer Key ...... 35
,---
Exam Overview
The BSN HESI 315 Pharmacology Exam V2 is a comprehensive pharmacology assessment
designed for Bachelor of Science in Nursing (BSN) students. This examination evaluates mastery
of pharmacological principles, medication administration, drug classifications, adverse effects,
nursing interventions, and patient education across all body systems.
| Exam Detail | Information |
|-------------|-------------|
| Course | HESI 315: Pharmacology |
| Format | Multiple-choice, select-all-that-apply, clinical scenarios |
| Key Topics | Pharmacokinetics, drug classifications, adverse effects, nursing interventions,
patient education, dosage calculations |
| Passing Score | Typically 850–900 (scaled) |
Core Competencies Assessed:
- Pharmacokinetics & Pharmacodynamics — Absorption, distribution, metabolism, excretion,
receptor theory
- Autonomic Nervous System Drugs — Cholinergics, anticholinergics, adrenergics, adrenergic
blockers
- Central Nervous System Drugs — Antidepressants, antipsychotics, anxiolytics, anticonvulsants,
Parkinson's drugs
- Cardiovascular Drugs — Antihypertensives, antiarrhythmics, anticoagulants, cardiac glycosides
- Respiratory & Endocrine Drugs — Bronchodilators, steroids, insulin, thyroid medications
,- Antibiotics & Anti-Infectives — Penicillins, cephalosporins, aminoglycosides, antifungals,
antivirals
- GI, Renal, & Reproductive Drugs — Antacids, diuretics, hormonal contraceptives
- Oncology & Immunosuppressants — Chemotherapeutic agents, immunosuppressants
- Nursing Considerations — Medication administration, adverse effects, patient education,
safety
---
Domain 1: Pharmacokinetics & Pharmacodynamics (Questions 1–40)
---
Q1. A nurse is reviewing the pharmacokinetics of a medication. Which phase describes the
movement of a drug from the site of administration into the bloodstream?
A) Distribution
B) Metabolism
C) Absorption
D) Excretion
Answer: C
Rationale: Absorption is the process by which a medication moves from the site of
administration into the bloodstream. Distribution refers to the transport of the drug to tissues
and organs. Metabolism is the biotransformation of the drug. Excretion is the elimination of the
drug from the body.
, ---
Q2. A client is prescribed a medication that is highly protein-bound. Which of the following is a
potential risk associated with this type of medication?
A) Increased drug excretion
B) Decreased drug absorption
C) Drug interactions due to displacement from protein binding sites
D) Increased drug metabolism
Answer: C
Rationale: Highly protein-bound medications can interact with other highly protein-bound
drugs. When two protein-bound drugs are administered, they compete for binding sites,
potentially displacing one drug and increasing the concentration of free (active) drug, which can
lead to toxicity.
---
Q3. A nurse is educating a client about a medication that is metabolized by the liver. The client
has a history of liver disease. Which of the following effects should the nurse anticipate?
A) Decreased drug effect
B) Prolonged drug effect and increased risk of toxicity
C) No change in drug effect
D) Increased drug excretion
